Molecule-nyheter

VitaDAO has raised $4.1 million from Pfizer Ventures among other investors. The latest fund raiser will fund longevity research projects and the development of its first biotech startup. VitaDAO has raised $4.1 million from Pfizer Ventures among...

Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to...